[Arterial occlusion associated with interaction between ritonavir and ergotamine in HIV patient]

MeSH terms

• Adult
• Anticoagulants / therapeutic use
• Arm / blood supply
• Arterial Occlusive Diseases / chemically induced*
• Arterial Occlusive Diseases / drug therapy
• Cytochrome P-450 CYP3A
• Cytochrome P-450 CYP3A Inhibitors*
• Drug Combinations
• Drug Interactions
• Drug Therapy, Combination
• Ergotamine / adverse effects*
• Ergotamine / pharmacokinetics
• Ergotamine / therapeutic use
• Female
• HIV Infections / complications
• HIV Infections / drug therapy*
• HIV Protease Inhibitors / adverse effects*
• HIV Protease Inhibitors / pharmacokinetics
• HIV Protease Inhibitors / therapeutic use
• Humans
• Inactivation, Metabolic
• Ischemia / chemically induced*
• Ischemia / drug therapy
• Microsomes, Liver / drug effects
• Microsomes, Liver / enzymology
• Migraine without Aura / complications
• Migraine without Aura / drug therapy*
• Ritonavir / adverse effects*
• Ritonavir / pharmacokinetics
• Ritonavir / therapeutic use
• Thrombolytic Therapy
• Vasoconstrictor Agents / adverse effects*
• Vasoconstrictor Agents / pharmacokinetics
• Vasoconstrictor Agents / therapeutic use